Partners Gpe VIII Limited Partnership Advent serves as Executive at Syneos Health, Inc., where they oversee executive responsibilities. Since joining the company, Partners Gpe VIII Limited Partnership Advent has executed 2 insider transactions totaling $205.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 3, 2023 involved selling 450,000 shares valued at $7.4M.
Partners Gpe VIII Limited Partnership Advent currently holds 34,089,784 shares of Syneos Health, Inc. (SYNH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Partners Gpe VIII Limited Partnership Advent has been a net seller of SYNH stock. They have purchased $0 and sold $205.2M worth of shares.
Partners Gpe VIII Limited Partnership Advent's most recent insider trade was on Jul 3, 2023, when they sold 450,000 shares at $16.42 per share.
Get notified when new Form 4 filings are submitted
| $61.28 |
| Discretionary |